Matthew T David Cor Medix Inc. (CRMD) insider trading activity

Matthew T David is Chief Financial Officer of CorMedix Inc.. Currently has a direct ownership of 95,270 shares of CRMD, which is worth approximately $1.02 Million. The most recent transaction as insider was on Jan 10, 2025, when has been sold 6,515 shares (Common Stock) at a price of $11.19 per share, resulting in proceeds of $72,902. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 95.3K

98.75% 3M change

98.75% 12M change

Total Value Held $1.02 Million

Matthew T David Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 10 2025	SELL Payment of exercise price or tax liability	$72,902 $11.19 p/Share	6,515 Reduced 6.4%	95,270 Common Stock
Jan 02 2025	SELL Payment of exercise price or tax liability	$71,086 $8.22 p/Share	8,648 Reduced 7.83%	101,786 Common Stock
Jan 02 2025	BUY Grant, award, or other acquisition	-	62,500 Added 36.14%	110,434 Common Stock
Jan 12 2024	SELL Payment of exercise price or tax liability	$18,099 $3.47 p/Share	5,216 Reduced 9.81%	47,934 Common Stock
Jan 12 2024	BUY Grant, award, or other acquisition	-	50,000 Added 48.47%	53,150 Common Stock
Dec 06 2021	BUY Open market or private purchase	$4,500 $4.5 p/Share	1,000 Added 24.1%	3,150 Common Stock
Dec 06 2021	BUY Open market or private purchase	$4,500 $4.5 p/Share	1,000 Added 24.1%	3,150 Common Stock
Nov 17 2021	BUY Open market or private purchase	$5,070 $5.07 p/Share	1,000 Added 31.75%	2,150 Common Stock

MTD

Matthew T David

Chief Financial Officer

Berkeley Heights, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRMD shares.

Notify only if

Value

Insider Trading

Get notified when an Cor Medix Inc. insider buys or sells CRMD shares.

Notify only if

Operation

Value

Type

News

Receive news related to CorMedix Inc.

Track Activities on CRMD

Account